Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways.
about
Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligandNew insights into the possible role of bacteriophages in host defense and diseaseToll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses.Respiratory syncytial virus limits alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) phosphorylation to maintain translation and viral replicationProtective effect of Toll-like receptor 4 in pulmonary vaccinia infectionOxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection.Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression.Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro.The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxinAlpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection.Role of Toll-like receptors in host responses to a virulence antigen of Streptococcus mutans expressed by a recombinant, attenuated Salmonella vector vaccine.Innate immune recognition of respiratory syncytial virus infection.New insights for development of a safe and protective RSV vaccineAlveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infectionAnimal pneumoviruses: molecular genetics and pathogenesis.The airway epithelium: soldier in the fight against respiratory virusesRespiratory syncytial virus represses glucocorticoid receptor-mediated gene activation.A systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus.Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodiesAtaxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection.Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis.RNA-sequence analysis of primary alveolar macrophages after in vitro infection with porcine reproductive and respiratory syndrome virus strains of differing virulence.Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells.Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response.RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection.Mechanical ventilation modulates Toll-like receptors 2, 4, and 9 on alveolar macrophages in a ventilator-induced lung injury model.Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.Toll-like receptors: function and roles in lung disease.Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.Inhibition of airway Na+ transport by respiratory syncytial virus.Signal transduction pathways of tumor necrosis factor--mediated lung injury induced by ozone in mice.Temporal activation of NF-kappaB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses.Dendritic cells in viral pathogenesis: protective or defective?Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection.Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunitiesRespiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion.Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease developmentInduction of DNA double-strand breaks and cellular senescence by human respiratory syncytial virus.Human genetic factors and respiratory syncytial virus disease severity.IkappaB kinase is a critical regulator of chemokine expression and lung inflammation in respiratory syncytial virus infection.
P2860
Q24683245-D0637B9B-EFF1-4321-92BB-0F34E925CF5CQ24804005-D35612DE-6B28-4FC6-8B29-00643DF92698Q30400432-F5869AAF-E240-41A8-815D-687263C6A858Q30431312-679815FB-243B-42E4-BAD9-42F919433B88Q33370547-D886A147-FB2A-48A9-A012-6FE14FE1FF29Q33374284-B8B232B8-A268-463F-A9F9-06C50447D5B7Q33737766-C959472B-7347-465C-808E-8F8F07A0BF10Q33784124-1D1B2FFC-1E10-46B4-B969-F320B3FE8484Q33863111-7C711C85-14C2-4655-9889-5CA9C0BFBC3CQ33887844-28176A1F-3B7A-4A7D-8745-5678864F97A0Q34021831-6198FE8E-56DA-486B-8494-3130BB427388Q34180049-58C5C0A0-EB10-4A5F-AD03-1E9AA3BA4E03Q34249859-0E0C18C3-55F8-456A-86F8-392C0AD562FFQ34305520-3AD47DE5-6463-42C7-BA03-EBA150EA82E1Q34313560-A6D953E4-B3EF-4330-8572-EBC1BE29889AQ34491598-F10F8072-7C5C-435A-A45B-170BA89449B3Q34566553-C6BAE23D-9A2A-4BDC-B861-D37EDC8D41C9Q34626385-51D8FA33-E487-417F-AD8B-3E11ECBCA271Q35058641-54ACDC15-27D0-4B2A-9E12-9F15F838E23EQ35076663-86D48FEA-DF93-452C-BF26-C103927B3498Q35107695-1AFD0172-9FA7-480D-BD02-1B2202237F00Q35124260-7E4E0FC4-F198-4053-8EC2-0BFAA74AFD63Q35185439-A60FAC57-162E-4035-8FB9-110C85F18F8EQ35217016-91CD444B-6294-42C9-832D-E64AA02864BAQ35531231-22BB401D-0809-411B-969E-A0EA9056E128Q35568345-40B03A83-E1D6-4177-BAED-402E07B668CFQ35599372-3F402E72-2E66-4AC3-8166-5B63954C06B0Q35738175-90160847-D219-4570-B284-65FC5F596E1FQ35742370-C361BA6E-0DCC-42D7-8E9A-9D4A4D10F253Q35785372-7ACF5D52-230C-407C-9201-F8293FD2E104Q35855209-8FD29692-A110-44CC-BEF1-E484EE023280Q35978609-733247A8-6C4F-44B7-9290-B27E69EB6405Q36207868-30689082-8D85-4A29-87FA-CAEEBA17943AQ36322131-64CF7003-DBAE-4861-AB6F-59098A26001AQ36444085-48668850-BAF4-4DE1-9307-205DEE24D5D5Q36530226-1CACE0A8-06D7-4493-A9B2-48BFC78AB67EQ36540154-9D03C220-FF32-447F-814B-63B64C84F948Q36913291-42F0AFBA-63A4-42C0-8567-6099DFDDA271Q36943137-B29FF6D5-F141-44F2-A842-B3E5702204C1Q36955209-19B8FAAF-6515-4602-8E7B-CC8A92FDA62C
P2860
Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Respiratory syncytial virus-in ...... receptor 4-dependent pathways.
@en
Respiratory syncytial virus-in ...... receptor 4-dependent pathways.
@nl
type
label
Respiratory syncytial virus-in ...... receptor 4-dependent pathways.
@en
Respiratory syncytial virus-in ...... receptor 4-dependent pathways.
@nl
prefLabel
Respiratory syncytial virus-in ...... receptor 4-dependent pathways.
@en
Respiratory syncytial virus-in ...... receptor 4-dependent pathways.
@nl
P2093
P356
P1476
Respiratory syncytial virus-in ...... receptor 4-dependent pathways.
@en
P2093
Allan R Brasier
Antonella Casola
Hans-Juergen Dieterich
Helene A Haeberle
Nico Van Rooijen
Roberto P Garofalo
Ryuta Takizawa
Zoran Gatalica
P304
P356
10.1086/344644
P407
P577
2002-10-11T00:00:00Z